BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4084733)

  • 1. Generalised increase in bone resorption in carcinoma of the prostate.
    Urwin GH; Percival RC; Harris S; Beneton MN; Williams JL; Kanis JA
    Br J Urol; 1985 Dec; 57(6):721-3. PubMed ID: 4084733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphometric evidence for bone resorption and replacement in prostate cancer.
    Clarke NW; McClure J; George NJ
    Br J Urol; 1991 Jul; 68(1):74-80. PubMed ID: 1873694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption.
    Percival RC; Urwin GH; Harris S; Yates AJ; Williams JL; Beneton M; Kanis JA
    Eur J Surg Oncol; 1987 Feb; 13(1):41-9. PubMed ID: 3102281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction between focally accelerated bone formation and osteomalacia in carcinoma of prostate metastasised to bone.
    Taube T; Beneton MN; Williams JL; McCloskey EV; Kanis JA
    Br J Urol; 1993 Jul; 72(1):98-103. PubMed ID: 8149187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal response to clodronate in prostate cancer with bone metastases.
    Fernández-Conde M; Alcover J; Aaron JE; Ordi J; Carretero P
    Am J Clin Oncol; 1997 Oct; 20(5):471-6. PubMed ID: 9345330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates in prostate carcinoma.
    Adami S
    Cancer; 1997 Oct; 80(8 Suppl):1674-9. PubMed ID: 9362435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal effects of carcinoma of the breast and prostate.
    Percival RC
    Ann R Coll Surg Engl; 1986 Sep; 68(5):267-70. PubMed ID: 3789624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of prostaglandin E-EP4 signaling in osteoblasts prevents the bone destruction induced by human prostate cancer metastases.
    Watanabe K; Tominari T; Hirata M; Matsumoto C; Maruyama T; Murphy G; Nagase H; Miyaura C; Inada M
    Biochem Biophys Res Commun; 2016 Sep; 478(1):154-161. PubMed ID: 27450806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoblast function and osteomalacia in metastatic prostate cancer.
    Clarke NW; McClure J; George NJ
    Eur Urol; 1993; 24(2):286-90. PubMed ID: 8375452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption.
    Taube T; Beneton MN; McCloskey EV; Rogers S; Greaves M; Kanis JA
    Eur J Haematol; 1992 Oct; 49(4):192-8. PubMed ID: 1464362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer.
    Taube T; Elomaa I; Blomqvist C; Beneton MN; Kanis JA
    Bone; 1994; 15(2):161-6. PubMed ID: 8086233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal tubular reabsorption of phosphate is positively related to the extent of bone metastatic load in patients with prostate cancer.
    Buchs N; Bonjour JP; Rizzoli R
    J Clin Endocrinol Metab; 1998 May; 83(5):1535-41. PubMed ID: 9589651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of osteoblastic bone metastasis of prostate cancer].
    Yonou H; Ogawa Y; Ochiai A
    Clin Calcium; 2006 Apr; 16(4):557- 64. PubMed ID: 16582505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma.
    Berruti A; Tucci M; Dogliotti L; Scarpa RM; Angeli A
    Cancer; 2002 Sep; 95(5):1182-3; author reply 1183-4. PubMed ID: 12209706
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathophysiology of bone metastases in urologic carcinomas].
    Sauer G; Barth TF; Möller P
    Urologe A; 2007 Aug; 46(8):888-90. PubMed ID: 17632696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteolytic and osteoblastic metastases due to carcinoid tumors.
    Manoli RS; Barthelemy CR
    Clin Nucl Med; 1980 Mar; 5(3):102-5. PubMed ID: 7357764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biphosphonates in the treatment of bone metastasis of prostatic cancer].
    Paule B; Cicco A
    Prog Urol; 2001 Dec; 11(6):1205-12. PubMed ID: 11859653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does increased local bone resorption secondary to breast and prostate cancer result in increased cartilage degradation?
    Leeming DJ; Byrjalsen I; Qvist P; Koizumi M; Lynnerup N; Fregerslev M; Sørensen MG; Christiansen C; Karsdal MA
    BMC Cancer; 2008 Jun; 8():180. PubMed ID: 18588674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraosseous growth of human prostate cancer in implanted adult human bone: relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions.
    Yonou H; Ochiai A; Goya M; Kanomata N; Hokama S; Morozumi M; Sugaya K; Hatano T; Ogawa Y
    Prostate; 2004 Mar; 58(4):406-13. PubMed ID: 14968441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer and bone: the elective affinities.
    Rucci N; Angelucci A
    Biomed Res Int; 2014; 2014():167035. PubMed ID: 24971315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.